Cargando…
How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring
For using counts of circulating tumor cells (CTCs) in the clinic to aid a physician's decision, its reported values will need to be accurate and comparable between institutions. Many technologies have become available to enumerate and characterize CTCs, thereby showing a large range of reported...
Autores principales: | Zeune, Leonie L., de Wit, Sanne, Berghuis, A.M. Sofie, IJzerman, Maarten J., Terstappen, Leon W.M.M., Brune, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585854/ https://www.ncbi.nlm.nih.gov/pubmed/30246927 http://dx.doi.org/10.1002/cyto.a.23576 |
Ejemplares similares
-
Blood‐based biopsies—clinical utility beyond circulating tumor cells
por: Tang, Cha‐Mei, et al.
Publicado: (2018) -
The RareCyte® platform for next‐generation analysis of circulating tumor cells
por: Kaldjian, Eric P., et al.
Publicado: (2018) -
The Parsortix™ Cell Separation System—A versatile liquid biopsy platform
por: Miller, M. Craig, et al.
Publicado: (2018) -
Centrifugation affects the purity of liquid biopsy‐based tumor biomarkers
por: Rikkert, Linda G., et al.
Publicado: (2018) -
Automated rare single cell picking with the ALS cellcelector™
por: Nelep, Constantin, et al.
Publicado: (2018)